A popular phrase in tumor immunology is that an effective intratumoral intervention can “turn the tumor into a vaccine.” The phrase is useful because it points at a real mechanistic aspiration: use the tumor itself as the antigen source, then supply the right inflammatory context so the immune system generates tumor-specific T cells capable of […]

Intratumoral therapy is often described as a change in delivery route: instead of dosing a drug systemically and hoping adequate exposure reaches the tumor, clinicians place therapy directly into malignant tissue. That description is accurate but incomplete. The deeper idea is that intratumoral immunotherapy treats cancer as a systems problem—one governed by spatial constraints, time-dependent […]

In cancer medicine, there’s a persistent paradox: the most obvious target is often the hardest to control. A solid tumor is visible on scans, reachable by needles and catheters, and measurable in size—yet it can behave like a hub in a distributed network. Treat one lesion and the disease may still progress elsewhere. Treat the […]